Page 7 - Flipbook for Biotech Showcase 2019

LITIGATION
We have an outstanding litigation practice, particularly in areas of significance to life science companies. Our clients turn to us to sort out complex rights issues to resolve collaboration, consortium, and joint venture disputes. We protect from trade secrets theft. We defend against, and manage, product liability matters. In addition, we litigate licensing disputes related to patent rights and other intellectual property, as well as handle international arbitrations for life sciences companies.
Our patent attorneys have diverse training and industry experience in a wide variety of technologies. Examples of some of the degrees held by members of our Patent team include: degrees in plant biology and physics; biology, psychobiology, biochemistry, biomedical engineering, and physics.
Sheppard Mullin’s patent litigators have handled cases throughout the United States, including all of the district courts known for handling major patent cases—C.D. Cal., N.D. Cal., D. Del., E.D. Va, E.D. Tex., D. N.J., N.D. Ill, S.D.N.Y., D. Mass.—as well as the Supreme Court, the Federal Circuit, the U.S. International Trade Commission, and numerous other district courts. As a result, our attorneys have deep and broad expertise in all phases of patent litigation from pre-litigation counseling through Markman hearings, dispositive motions, jury trials, and appeals.
ANTITRUST AND COMPETITION
Over the years, our Antitrust and Competition attorneys have advised a number of the leading originator, biologic, healthcare, and medical devices companies. This experience relates to cartel, abuse of dominance and merger control law, particularly to patent settlements, licensing, originator/generic competition, lifecycle management, R&D, co-marketing/co-promotion agreements, pricing/reimbursement issues, supplemental protection certificates, parallel imports, supply and distribution, quota schemes, and refusal to supply/license.
We also assist clients with advice on all aspects of EU and national pharmaceutical regulation including product safety, clinical trials, dealings with HCPs, manufacturing agreements, product classification, market access, CE marking, data and regulatory exclusivity, and supply and distribution.
In addition to counseling and work relating to agency investigations, our experts advise clients on litigation in front of EU Courts, and also on private litigation in national courts, where an increasing amount of competition and regulatory disputes are being fought.
Some of our attorneys have previously worked at the European Commission pharmaceutical and cosmetic unit and are, thus, well-connected with the agencies.
BANKRUPTCY AND CREDITORS’ RIGHTS
Our clients are advantaged by our broad base of skills in bankruptcy and workout situations. We understand all the facets, have counseled, and represented secured and unsecured creditors, creditors’ committees, trustees, debtors, and all other interested parties in their debtor-creditor relationships so we can help clients anticipate and prepare for adverse contingencies and opportunities. In bankruptcy and other judicial proceedings, out-of-court restructuring and liquidations, as well as in the transactional side of the practice, we are litigators, negotiators, theoreticians, practitioners and draftsmen – attorneys and counselors in the true sense of those words. We represent clients in all types of regional, national, and international insolvency matters ranging in size and complexity from out of court loan workouts and financial restructurings to bankruptcy proceedings, creditors’ rights issues, and distressed acquisitions.